Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.53796462 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.53796462 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.97860021 |
4 | negative regulation of cell killing (GO:0031342) | 4.24311413 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.24311413 |
6 | response to peptidoglycan (GO:0032494) | 4.03985048 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84450414 |
8 | neutrophil activation involved in immune response (GO:0002283) | 3.70490314 |
9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63116430 |
10 | detection of bacterium (GO:0016045) | 3.61890060 |
11 | detection of other organism (GO:0098543) | 3.59175501 |
12 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41160983 |
13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39867384 |
14 | response to muramyl dipeptide (GO:0032495) | 3.31302271 |
15 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.26437362 |
16 | valine metabolic process (GO:0006573) | 3.17555462 |
17 | regulation of mast cell degranulation (GO:0043304) | 3.16707706 |
18 | pentose-phosphate shunt (GO:0006098) | 3.12005893 |
19 | positive regulation of histone deacetylation (GO:0031065) | 3.11895255 |
20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02035048 |
21 | positive thymic T cell selection (GO:0045059) | 2.99673779 |
22 | regulation of leukocyte degranulation (GO:0043300) | 2.95253027 |
23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94905157 |
24 | macrophage activation involved in immune response (GO:0002281) | 2.93264047 |
25 | leukocyte aggregation (GO:0070486) | 2.90471719 |
26 | germinal center formation (GO:0002467) | 2.89735296 |
27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87360002 |
28 | maternal placenta development (GO:0001893) | 2.85693633 |
29 | morphogenesis of an endothelium (GO:0003159) | 2.85295816 |
30 | endothelial tube morphogenesis (GO:0061154) | 2.85295816 |
31 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85111847 |
32 | detection of external biotic stimulus (GO:0098581) | 2.84924052 |
33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83780784 |
34 | NIK/NF-kappaB signaling (GO:0038061) | 2.83643718 |
35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83459712 |
36 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.78861371 |
37 | DNA deamination (GO:0045006) | 2.76852857 |
38 | folic acid metabolic process (GO:0046655) | 2.76832411 |
39 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73908129 |
40 | positive regulation of protein deacetylation (GO:0090312) | 2.72220177 |
41 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71980409 |
42 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71904637 |
43 | response to host immune response (GO:0052572) | 2.71008878 |
44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.71008878 |
45 | protein localization to endosome (GO:0036010) | 2.67384790 |
46 | NADPH regeneration (GO:0006740) | 2.66659896 |
47 | natural killer cell differentiation (GO:0001779) | 2.64664990 |
48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63392774 |
49 | response to host (GO:0075136) | 2.63392774 |
50 | response to host defenses (GO:0052200) | 2.63392774 |
51 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62030525 |
52 | positive regulation of B cell differentiation (GO:0045579) | 2.61972091 |
53 | amino sugar catabolic process (GO:0046348) | 2.60741807 |
54 | defense response to protozoan (GO:0042832) | 2.59528489 |
55 | modulation by symbiont of host cellular process (GO:0044068) | 2.58644113 |
56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58284162 |
57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56701360 |
58 | regulation of necrotic cell death (GO:0010939) | 2.56568097 |
59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55897978 |
60 | mannose metabolic process (GO:0006013) | 2.55419121 |
61 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.54197602 |
62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52095587 |
63 | granulocyte activation (GO:0036230) | 2.51518233 |
64 | tolerance induction (GO:0002507) | 2.51129227 |
65 | modulation by virus of host process (GO:0019054) | 2.50225559 |
66 | negative regulation of stress fiber assembly (GO:0051497) | 2.50118419 |
67 | response to protozoan (GO:0001562) | 2.49999847 |
68 | response to laminar fluid shear stress (GO:0034616) | 2.49412086 |
69 | cellular extravasation (GO:0045123) | 2.47989260 |
70 | neutrophil activation (GO:0042119) | 2.47008925 |
71 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44684901 |
72 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43847798 |
73 | myeloid cell activation involved in immune response (GO:0002275) | 2.43576450 |
74 | thymic T cell selection (GO:0045061) | 2.43005022 |
75 | regulation of antigen processing and presentation (GO:0002577) | 2.42867405 |
76 | detection of biotic stimulus (GO:0009595) | 2.42524537 |
77 | * regulation of response to interferon-gamma (GO:0060330) | 2.42290422 |
78 | immunoglobulin mediated immune response (GO:0016064) | 2.42284261 |
79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41040450 |
80 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.40069791 |
81 | formation of translation preinitiation complex (GO:0001731) | 2.39919882 |
82 | negative regulation of interleukin-6 production (GO:0032715) | 2.39859610 |
83 | apoptotic process involved in morphogenesis (GO:0060561) | 2.38448084 |
84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37808543 |
85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.37642904 |
86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37629109 |
87 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.37453747 |
88 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.37084898 |
89 | regulation of defense response to virus by virus (GO:0050690) | 2.37074826 |
90 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.36768126 |
91 | T cell apoptotic process (GO:0070231) | 2.36698256 |
92 | negative regulation of cell size (GO:0045792) | 2.35608854 |
93 | * regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.35177281 |
94 | glucose catabolic process (GO:0006007) | 2.34496412 |
95 | B cell receptor signaling pathway (GO:0050853) | 2.33933587 |
96 | negative regulation of interleukin-12 production (GO:0032695) | 2.33827171 |
97 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.33757115 |
98 | regulation of regulated secretory pathway (GO:1903305) | 2.33651040 |
99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33119220 |
100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32496016 |
101 | regulation of translational termination (GO:0006449) | 2.31271501 |
102 | T cell selection (GO:0045058) | 2.31035783 |
103 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.31002154 |
104 | respiratory burst (GO:0045730) | 2.30610425 |
105 | tricarboxylic acid metabolic process (GO:0072350) | 2.30524023 |
106 | regulation of tumor necrosis factor production (GO:0032680) | 2.30452964 |
107 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.30407019 |
108 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.30334655 |
109 | cellular hyperosmotic response (GO:0071474) | 2.30326022 |
110 | autophagic vacuole fusion (GO:0000046) | 2.29251407 |
111 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28723948 |
112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.28338553 |
113 | regulation of B cell differentiation (GO:0045577) | 2.27779492 |
114 | mitotic G1/S transition checkpoint (GO:0044819) | 2.25724469 |
115 | * negative regulation of innate immune response (GO:0045824) | 2.22405713 |
116 | pinocytosis (GO:0006907) | 2.22138814 |
117 | low-density lipoprotein particle clearance (GO:0034383) | 2.21372178 |
118 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.18175639 |
119 | glycine metabolic process (GO:0006544) | 2.17556462 |
120 | positive regulation of lamellipodium assembly (GO:0010592) | 2.16951240 |
121 | endothelial cell chemotaxis (GO:0035767) | 2.15612653 |
122 | sulfur amino acid catabolic process (GO:0000098) | 2.12848343 |
123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.12298185 |
124 | B cell mediated immunity (GO:0019724) | 2.12202969 |
125 | lymphocyte apoptotic process (GO:0070227) | 2.11254313 |
126 | apoptotic cell clearance (GO:0043277) | 2.10531624 |
127 | regulation of superoxide anion generation (GO:0032928) | 2.10071256 |
128 | lysine metabolic process (GO:0006553) | 2.09860485 |
129 | lysine catabolic process (GO:0006554) | 2.09860485 |
130 | regulation of translational fidelity (GO:0006450) | 2.09802791 |
131 | trophectodermal cell differentiation (GO:0001829) | 2.09348153 |
132 | nucleotide salvage (GO:0043173) | 2.09173525 |
133 | negative thymic T cell selection (GO:0045060) | 2.07883029 |
134 | response to type I interferon (GO:0034340) | 2.07172261 |
135 | viral transcription (GO:0019083) | 2.05163687 |
136 | regulation of erythrocyte differentiation (GO:0045646) | 2.04765690 |
137 | ribosomal small subunit assembly (GO:0000028) | 2.02307762 |
138 | cellular response to type I interferon (GO:0071357) | 2.02211871 |
139 | type I interferon signaling pathway (GO:0060337) | 2.02211871 |
140 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.01732668 |
141 | positive regulation of interferon-alpha production (GO:0032727) | 2.00675021 |
142 | positive regulation of natural killer cell differentiation (GO:0032825) | 1.99713870 |
143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 1.99048067 |
144 | cellular response to virus (GO:0098586) | 1.99032707 |
145 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.98496209 |
146 | negative T cell selection (GO:0043383) | 1.97972363 |
147 | positive regulation of lamellipodium organization (GO:1902745) | 1.97154343 |
148 | barbed-end actin filament capping (GO:0051016) | 1.94263671 |
149 | translational elongation (GO:0006414) | 1.94240098 |
150 | * regulation of cholesterol storage (GO:0010885) | 1.93995363 |
151 | modulation by symbiont of host defense response (GO:0052031) | 1.93597775 |
152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.93597775 |
153 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.93597775 |
154 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.93597775 |
155 | modulation by symbiont of host immune response (GO:0052553) | 1.93597775 |
156 | positive regulation by symbiont of host defense response (GO:0052509) | 1.93597775 |
157 | cellular response to interleukin-4 (GO:0071353) | 1.92757181 |
158 | COPI coating of Golgi vesicle (GO:0048205) | 1.92552254 |
159 | Golgi transport vesicle coating (GO:0048200) | 1.92552254 |
160 | cysteine metabolic process (GO:0006534) | 1.91892686 |
161 | translational termination (GO:0006415) | 1.91641047 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.97884048 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 2.91733541 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.83738291 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.74363951 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38994394 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38179767 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25259583 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21192767 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09085916 |
10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.06997057 |
11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90419322 |
12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.85648557 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84687260 |
14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83287353 |
15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74812253 |
16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74478731 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 1.72832671 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65494829 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.65454707 |
20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60309483 |
21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.60156266 |
22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57437800 |
23 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.55781790 |
24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55499987 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54865152 |
26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53466780 |
27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52785668 |
28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52687536 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52531577 |
30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52359333 |
31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51296658 |
32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45108813 |
33 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44430448 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44119637 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42916559 |
36 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42647700 |
37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42081654 |
38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41678203 |
39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40711981 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40093012 |
41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39772036 |
42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39759670 |
43 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39615789 |
44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37812016 |
45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36056567 |
46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35974116 |
47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34869536 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33392519 |
49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32981093 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32471092 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32137380 |
52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31697568 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30900966 |
54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30738682 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.30490480 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28930413 |
57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28719617 |
58 | MYB_26560356_Chip-Seq_TH1_Human | 1.27641794 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27370318 |
60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26173994 |
61 | MYB_26560356_Chip-Seq_TH2_Human | 1.25271436 |
62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24764661 |
63 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24588169 |
64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24561036 |
65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24400193 |
66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24302104 |
67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24145917 |
68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23648415 |
69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23415634 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23298346 |
71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23123312 |
72 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23002910 |
73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22814655 |
74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22711693 |
75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21615400 |
76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21586972 |
77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21161010 |
78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20228872 |
79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20153175 |
80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18211581 |
81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18107303 |
82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17778679 |
83 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17636804 |
84 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17302346 |
85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16038327 |
86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15457772 |
87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13338219 |
88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13255458 |
89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13080313 |
90 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13051654 |
91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12584697 |
92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12167247 |
93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12158482 |
94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11945459 |
95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11705374 |
96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11425522 |
97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11349953 |
98 | * P68_20966046_ChIP-Seq_HELA_Human | 1.11146761 |
99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10326243 |
100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09946901 |
101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09818855 |
102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08681748 |
103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08549262 |
104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07998096 |
105 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07905022 |
106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07901921 |
107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06757475 |
108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06325845 |
109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05656452 |
110 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.05200003 |
111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03997651 |
112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03193099 |
113 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02193465 |
114 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01521005 |
115 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01267400 |
116 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00987855 |
117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00827768 |
118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99883867 |
119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99731224 |
120 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99140676 |
121 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99108173 |
122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98609146 |
123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98158923 |
124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97719530 |
125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96835757 |
126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93929189 |
127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93513276 |
128 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92443568 |
129 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92108528 |
130 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92023924 |
131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91544033 |
132 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91188347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 2.72348471 |
2 | MP0005451_abnormal_body_composition | 2.70919144 |
3 | MP0005360_urolithiasis | 2.43191988 |
4 | MP0000685_abnormal_immune_system | 2.42605228 |
5 | MP0008260_abnormal_autophagy | 2.40278641 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.29405332 |
7 | * MP0009840_abnormal_foam_cell | 2.09810655 |
8 | MP0003300_gastrointestinal_ulcer | 2.03779489 |
9 | MP0003436_decreased_susceptibility_to | 1.99670827 |
10 | MP0001835_abnormal_antigen_presentation | 1.97013063 |
11 | * MP0003191_abnormal_cellular_cholesterol | 1.90851924 |
12 | MP0003303_peritoneal_inflammation | 1.81611552 |
13 | MP0003075_altered_response_to | 1.78404311 |
14 | MP0003763_abnormal_thymus_physiology | 1.77603485 |
15 | MP0002396_abnormal_hematopoietic_system | 1.76366984 |
16 | MP0009333_abnormal_splenocyte_physiolog | 1.73567813 |
17 | MP0001853_heart_inflammation | 1.70854345 |
18 | MP0001800_abnormal_humoral_immune | 1.68591823 |
19 | * MP0001545_abnormal_hematopoietic_system | 1.66373175 |
20 | * MP0005397_hematopoietic_system_phenotyp | 1.66373175 |
21 | MP0005058_abnormal_lysosome_morphology | 1.63506780 |
22 | MP0003693_abnormal_embryo_hatching | 1.63143582 |
23 | * MP0009278_abnormal_bone_marrow | 1.60835823 |
24 | MP0005387_immune_system_phenotype | 1.59890211 |
25 | MP0001790_abnormal_immune_system | 1.59890211 |
26 | MP0010155_abnormal_intestine_physiology | 1.56321308 |
27 | MP0004947_skin_inflammation | 1.53896669 |
28 | MP0009785_altered_susceptibility_to | 1.52420879 |
29 | MP0002398_abnormal_bone_marrow | 1.52370144 |
30 | MP0002452_abnormal_antigen_presenting | 1.50476239 |
31 | MP0002998_abnormal_bone_remodeling | 1.49408573 |
32 | MP0005671_abnormal_response_to | 1.47396785 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.46997426 |
34 | MP0002405_respiratory_system_inflammati | 1.46428612 |
35 | MP0000689_abnormal_spleen_morphology | 1.46246452 |
36 | MP0002723_abnormal_immune_serum | 1.43325295 |
37 | MP0003566_abnormal_cell_adhesion | 1.43055585 |
38 | MP0005023_abnormal_wound_healing | 1.42868740 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.42705876 |
40 | * MP0005025_abnormal_response_to | 1.42632157 |
41 | MP0002722_abnormal_immune_system | 1.42573785 |
42 | MP0005000_abnormal_immune_tolerance | 1.41196541 |
43 | MP0005670_abnormal_white_adipose | 1.40638900 |
44 | MP0005464_abnormal_platelet_physiology | 1.39032050 |
45 | MP0002420_abnormal_adaptive_immunity | 1.38334938 |
46 | MP0001819_abnormal_immune_cell | 1.38172986 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.37558082 |
48 | MP0006082_CNS_inflammation | 1.36649151 |
49 | MP0000490_abnormal_crypts_of | 1.34123967 |
50 | * MP0000716_abnormal_immune_system | 1.32339299 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.31966392 |
52 | MP0010307_abnormal_tumor_latency | 1.29513311 |
53 | MP0002166_altered_tumor_susceptibility | 1.28759861 |
54 | MP0001873_stomach_inflammation | 1.26465467 |
55 | MP0002877_abnormal_melanocyte_morpholog | 1.26244244 |
56 | * MP0002429_abnormal_blood_cell | 1.25045552 |
57 | MP0002419_abnormal_innate_immunity | 1.24706938 |
58 | MP0005166_decreased_susceptibility_to | 1.23467397 |
59 | * MP0000609_abnormal_liver_physiology | 1.22845625 |
60 | MP0005076_abnormal_cell_differentiation | 1.22406362 |
61 | MP0003866_abnormal_defecation | 1.21452919 |
62 | MP0001845_abnormal_inflammatory_respons | 1.19661665 |
63 | MP0003111_abnormal_nucleus_morphology | 1.19238656 |
64 | MP0004957_abnormal_blastocyst_morpholog | 1.18621833 |
65 | MP0000858_altered_metastatic_potential | 1.18449905 |
66 | MP0003077_abnormal_cell_cycle | 1.17487814 |
67 | MP0000703_abnormal_thymus_morphology | 1.16211261 |
68 | MP0001849_ear_inflammation | 1.15440349 |
69 | MP0002933_joint_inflammation | 1.12524575 |
70 | MP0002138_abnormal_hepatobiliary_system | 1.12265836 |
71 | MP0003724_increased_susceptibility_to | 1.11232440 |
72 | MP0008438_abnormal_cutaneous_collagen | 1.10123152 |
73 | MP0001851_eye_inflammation | 1.09770497 |
74 | MP0009643_abnormal_urine_homeostasis | 1.08782767 |
75 | MP0005365_abnormal_bile_salt | 1.08696950 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.08601285 |
77 | MP0008469_abnormal_protein_level | 1.08447258 |
78 | * MP0005390_skeleton_phenotype | 1.08052248 |
79 | MP0005165_increased_susceptibility_to | 1.07304825 |
80 | MP0002019_abnormal_tumor_incidence | 1.06983716 |
81 | MP0003828_pulmonary_edema | 1.06886226 |
82 | MP0008004_abnormal_stomach_pH | 1.05955792 |
83 | MP0000751_myopathy | 1.03100386 |
84 | MP0005319_abnormal_enzyme/_coenzyme | 1.02949127 |
85 | MP0001958_emphysema | 1.02566078 |
86 | MP0008961_abnormal_basal_metabolism | 1.02343117 |
87 | MP0005083_abnormal_biliary_tract | 1.00735187 |
88 | * MP0001533_abnormal_skeleton_physiology | 0.98408076 |
89 | MP0002332_abnormal_exercise_endurance | 0.97683905 |
90 | MP0000343_altered_response_to | 0.97364967 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.96706271 |
92 | MP0004381_abnormal_hair_follicle | 0.95818597 |
93 | MP0002006_tumorigenesis | 0.95129557 |
94 | MP0003448_altered_tumor_morphology | 0.94898205 |
95 | * MP0000604_amyloidosis | 0.94252573 |
96 | MP0000598_abnormal_liver_morphology | 0.94231490 |
97 | MP0005666_abnormal_adipose_tissue | 0.94230961 |
98 | MP0003183_abnormal_peptide_metabolism | 0.93186501 |
99 | MP0004510_myositis | 0.92160988 |
100 | MP0003091_abnormal_cell_migration | 0.91655291 |
101 | MP0002148_abnormal_hypersensitivity_rea | 0.89934219 |
102 | MP0001730_embryonic_growth_arrest | 0.89639884 |
103 | MP0001542_abnormal_bone_strength | 0.88835681 |
104 | MP0005310_abnormal_salivary_gland | 0.88311999 |
105 | MP0002136_abnormal_kidney_physiology | 0.86979448 |
106 | MP0008874_decreased_physiological_sensi | 0.86301252 |
107 | MP0003279_aneurysm | 0.86141406 |
108 | MP0000350_abnormal_cell_proliferation | 0.85991859 |
109 | MP0000249_abnormal_blood_vessel | 0.85977122 |
110 | MP0002132_abnormal_respiratory_system | 0.85783026 |
111 | MP0010329_abnormal_lipoprotein_level | 0.85583519 |
112 | MP0004185_abnormal_adipocyte_glucose | 0.85124047 |
113 | MP0005164_abnormal_response_to | 0.84048990 |
114 | MP0003795_abnormal_bone_structure | 0.83823242 |
115 | MP0001663_abnormal_digestive_system | 0.83715725 |
116 | MP0003186_abnormal_redox_activity | 0.83273760 |
117 | MP0000747_muscle_weakness | 0.82548485 |
118 | MP0005085_abnormal_gallbladder_physiolo | 0.79654281 |
119 | MP0000750_abnormal_muscle_regeneration | 0.79250997 |
120 | MP0003172_abnormal_lysosome_physiology | 0.79021963 |
121 | MP0003252_abnormal_bile_duct | 0.77365791 |
122 | MP0000477_abnormal_intestine_morphology | 0.77272884 |
123 | MP0005332_abnormal_amino_acid | 0.76430495 |
124 | * MP0009763_increased_sensitivity_to | 0.76384598 |
125 | MP0004858_abnormal_nervous_system | 0.74989310 |
126 | MP0009764_decreased_sensitivity_to | 0.74674208 |
127 | MP0008007_abnormal_cellular_replicative | 0.73760891 |
128 | MP0000313_abnormal_cell_death | 0.72654428 |
129 | MP0001666_abnormal_nutrient_absorption | 0.72318135 |
130 | MP0000015_abnormal_ear_pigmentation | 0.72072811 |
131 | MP0004130_abnormal_muscle_cell | 0.70630386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.85751930 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.85751930 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.85751930 |
4 | Pustule (HP:0200039) | 3.31703954 |
5 | Abnormality of the nasal mucosa (HP:0000433) | 3.28888656 |
6 | Polycythemia (HP:0001901) | 3.17649103 |
7 | Nasal polyposis (HP:0100582) | 3.14620248 |
8 | Chronic otitis media (HP:0000389) | 3.11797220 |
9 | Distal lower limb muscle weakness (HP:0009053) | 3.08205092 |
10 | Eczematoid dermatitis (HP:0000976) | 3.04477076 |
11 | Increased cerebral lipofuscin (HP:0011813) | 2.88069678 |
12 | Vertebral compression fractures (HP:0002953) | 2.87847974 |
13 | Autoimmune thrombocytopenia (HP:0001973) | 2.87487281 |
14 | Orchitis (HP:0100796) | 2.77579423 |
15 | Stomatitis (HP:0010280) | 2.69363162 |
16 | Interstitial pulmonary disease (HP:0006530) | 2.68991656 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66530156 |
18 | Amyloidosis (HP:0011034) | 2.64678709 |
19 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63907698 |
20 | Obstructive lung disease (HP:0006536) | 2.63907698 |
21 | Purpura (HP:0000979) | 2.61196182 |
22 | IgM deficiency (HP:0002850) | 2.54767525 |
23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50107687 |
24 | Distal lower limb amyotrophy (HP:0008944) | 2.49181012 |
25 | Multiple enchondromatosis (HP:0005701) | 2.48515336 |
26 | Cerebral aneurysm (HP:0004944) | 2.48242650 |
27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47688122 |
28 | Petechiae (HP:0000967) | 2.44696492 |
29 | Gastrointestinal inflammation (HP:0004386) | 2.41289207 |
30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.40943217 |
31 | Cellulitis (HP:0100658) | 2.39590042 |
32 | J-shaped sella turcica (HP:0002680) | 2.38603724 |
33 | Recurrent fungal infections (HP:0002841) | 2.38483140 |
34 | Thrombocytosis (HP:0001894) | 2.38028721 |
35 | Meningitis (HP:0001287) | 2.35686700 |
36 | Recurrent bronchitis (HP:0002837) | 2.33858271 |
37 | Increased serum ferritin (HP:0003281) | 2.33414470 |
38 | Recurrent viral infections (HP:0004429) | 2.32156091 |
39 | Hepatosplenomegaly (HP:0001433) | 2.30466872 |
40 | Colitis (HP:0002583) | 2.26694990 |
41 | Inflammation of the large intestine (HP:0002037) | 2.24582620 |
42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.24462065 |
43 | Urticaria (HP:0001025) | 2.24234867 |
44 | Increased IgM level (HP:0003496) | 2.24142107 |
45 | Hypertensive crisis (HP:0100735) | 2.20866853 |
46 | Recurrent abscess formation (HP:0002722) | 2.18206884 |
47 | Agammaglobulinemia (HP:0004432) | 2.18039405 |
48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15772487 |
49 | Retrobulbar optic neuritis (HP:0100654) | 2.15389219 |
50 | Optic neuritis (HP:0100653) | 2.15389219 |
51 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.14706290 |
52 | Gastrointestinal infarctions (HP:0005244) | 2.14565650 |
53 | Myocardial infarction (HP:0001658) | 2.13626563 |
54 | Gingivitis (HP:0000230) | 2.13038523 |
55 | Abnormal platelet function (HP:0011869) | 2.12174705 |
56 | Impaired platelet aggregation (HP:0003540) | 2.12174705 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.09127440 |
58 | Spontaneous hematomas (HP:0007420) | 2.09100044 |
59 | Fatigue (HP:0012378) | 2.08040142 |
60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07718930 |
61 | Abnormal gallbladder physiology (HP:0012438) | 2.07710668 |
62 | Cholecystitis (HP:0001082) | 2.07710668 |
63 | Myopathic facies (HP:0002058) | 2.07685638 |
64 | Emphysema (HP:0002097) | 2.06575847 |
65 | Prolonged bleeding time (HP:0003010) | 2.05804052 |
66 | Abnormality of T cells (HP:0002843) | 2.05448574 |
67 | Mesangial abnormality (HP:0001966) | 2.04979944 |
68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03122424 |
69 | Vasculitis (HP:0002633) | 2.02724269 |
70 | Hand muscle atrophy (HP:0009130) | 2.02705558 |
71 | Hypergammaglobulinemia (HP:0010702) | 2.02004120 |
72 | Axonal loss (HP:0003447) | 2.01194978 |
73 | Achilles tendon contracture (HP:0001771) | 1.99660640 |
74 | Recurrent skin infections (HP:0001581) | 1.99001045 |
75 | Systemic lupus erythematosus (HP:0002725) | 1.98519412 |
76 | Exercise-induced myalgia (HP:0003738) | 1.97462718 |
77 | Abnormality of the fingertips (HP:0001211) | 1.97350770 |
78 | Increased IgE level (HP:0003212) | 1.96966402 |
79 | Gastrointestinal stroma tumor (HP:0100723) | 1.96483062 |
80 | Abnormality of iron homeostasis (HP:0011031) | 1.95226780 |
81 | Myositis (HP:0100614) | 1.94448563 |
82 | Hyperglycinuria (HP:0003108) | 1.93242670 |
83 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92961928 |
84 | Pulmonary infiltrates (HP:0002113) | 1.92375443 |
85 | Papilloma (HP:0012740) | 1.92066461 |
86 | Verrucae (HP:0200043) | 1.92066461 |
87 | Esophageal varix (HP:0002040) | 1.91634062 |
88 | Bulbar palsy (HP:0001283) | 1.90027672 |
89 | Polygenic inheritance (HP:0010982) | 1.90002238 |
90 | Joint stiffness (HP:0001387) | 1.89266384 |
91 | Panhypogammaglobulinemia (HP:0003139) | 1.88187975 |
92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88095093 |
93 | Gingival bleeding (HP:0000225) | 1.88041303 |
94 | Xanthomatosis (HP:0000991) | 1.86346644 |
95 | Hemorrhage of the eye (HP:0011885) | 1.86327088 |
96 | Dysostosis multiplex (HP:0000943) | 1.86122338 |
97 | Increased connective tissue (HP:0009025) | 1.85763717 |
98 | Gout (HP:0001997) | 1.84693878 |
99 | Osteomyelitis (HP:0002754) | 1.84633475 |
100 | Neuronal loss in central nervous system (HP:0002529) | 1.84003415 |
101 | Prolonged neonatal jaundice (HP:0006579) | 1.83095696 |
102 | Gastrointestinal dysmotility (HP:0002579) | 1.82639871 |
103 | Hematochezia (HP:0002573) | 1.81504657 |
104 | Vacuolated lymphocytes (HP:0001922) | 1.81339422 |
105 | Distal upper limb amyotrophy (HP:0007149) | 1.81240898 |
106 | Upper limb amyotrophy (HP:0009129) | 1.81240898 |
107 | Chest pain (HP:0100749) | 1.80564939 |
108 | Encephalitis (HP:0002383) | 1.80485994 |
109 | Granulocytopenia (HP:0001913) | 1.80044384 |
110 | Abnormality of the Achilles tendon (HP:0005109) | 1.79508743 |
111 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79114768 |
112 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79114768 |
113 | Asymmetric septal hypertrophy (HP:0001670) | 1.79039031 |
114 | T lymphocytopenia (HP:0005403) | 1.78325576 |
115 | Progressive neurologic deterioration (HP:0002344) | 1.78126556 |
116 | Mucopolysacchariduria (HP:0008155) | 1.77514684 |
117 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77514684 |
118 | Deep venous thrombosis (HP:0002625) | 1.75102885 |
119 | Rhabdomyolysis (HP:0003201) | 1.74855539 |
120 | Recurrent bacterial skin infections (HP:0005406) | 1.74811311 |
121 | Ulnar bowing (HP:0003031) | 1.74589961 |
122 | Spastic diplegia (HP:0001264) | 1.74098299 |
123 | Hyperacusis (HP:0010780) | 1.72637662 |
124 | Combined immunodeficiency (HP:0005387) | 1.72489770 |
125 | Reticulocytosis (HP:0001923) | 1.72414817 |
126 | Epistaxis (HP:0000421) | 1.71962264 |
127 | Abnormality of T cell number (HP:0011839) | 1.71633403 |
128 | Abnormality of macrophages (HP:0004311) | 1.71329124 |
129 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.69801071 |
130 | Ankle contracture (HP:0006466) | 1.69339599 |
131 | Aortic aneurysm (HP:0004942) | 1.69050981 |
132 | Nonimmune hydrops fetalis (HP:0001790) | 1.68870244 |
133 | Metaphyseal cupping (HP:0003021) | 1.68764624 |
134 | Difficulty climbing stairs (HP:0003551) | 1.68371665 |
135 | Hypertriglyceridemia (HP:0002155) | 1.67675641 |
136 | Mediastinal lymphadenopathy (HP:0100721) | 1.66967523 |
137 | Chondrocalcinosis (HP:0000934) | 1.66003938 |
138 | Abnormal cartilage morphology (HP:0002763) | 1.65031288 |
139 | Aneurysm (HP:0002617) | 1.64973828 |
140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64969049 |
141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64969049 |
142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64969049 |
143 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64921266 |
144 | Osteolytic defects of the hand bones (HP:0009699) | 1.64921266 |
145 | Selective tooth agenesis (HP:0001592) | 1.64610639 |
146 | Hypochromic anemia (HP:0001931) | 1.63543563 |
147 | Late onset (HP:0003584) | 1.62792512 |
148 | Abnormal number of erythroid precursors (HP:0012131) | 1.62749042 |
149 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.62717751 |
150 | Hypercholesterolemia (HP:0003124) | 1.60916330 |
151 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.60848916 |
152 | Increased density of long bones (HP:0006392) | 1.60676269 |
153 | Thoracic kyphosis (HP:0002942) | 1.60648000 |
154 | Loss of speech (HP:0002371) | 1.60568915 |
155 | Skin ulcer (HP:0200042) | 1.60079858 |
156 | Ulnar deviation of the wrist (HP:0003049) | 1.59567041 |
157 | Hyperammonemia (HP:0001987) | 1.57657328 |
158 | Trismus (HP:0000211) | 1.57081925 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.51601094 |
2 | ERN1 | 3.47805627 |
3 | MAP4K1 | 3.38680138 |
4 | PRPF4B | 3.34236187 |
5 | MAP3K10 | 3.14174529 |
6 | PKN2 | 2.73428309 |
7 | EEF2K | 2.71253548 |
8 | RIPK4 | 2.20817108 |
9 | ZAP70 | 2.00051002 |
10 | STK10 | 1.94405059 |
11 | FGFR4 | 1.93671503 |
12 | MAP2K3 | 1.93425241 |
13 | BCKDK | 1.81969266 |
14 | TYK2 | 1.79963526 |
15 | BLK | 1.68221645 |
16 | SMG1 | 1.67157227 |
17 | GRK6 | 1.66990382 |
18 | KDR | 1.63934851 |
19 | LRRK2 | 1.61538323 |
20 | TBK1 | 1.61297142 |
21 | MAP3K11 | 1.59807427 |
22 | ARAF | 1.59223682 |
23 | TESK2 | 1.55771598 |
24 | JAK3 | 1.55624745 |
25 | TGFBR2 | 1.55274143 |
26 | CDK12 | 1.53608247 |
27 | NEK2 | 1.52183938 |
28 | EPHB1 | 1.50825026 |
29 | NME2 | 1.48235737 |
30 | MAPKAPK3 | 1.48128349 |
31 | PTK6 | 1.44986282 |
32 | SIK1 | 1.44283569 |
33 | TTN | 1.44000785 |
34 | MAP3K13 | 1.43287411 |
35 | FLT3 | 1.41699252 |
36 | RPS6KA4 | 1.39265184 |
37 | FES | 1.37084595 |
38 | PAK4 | 1.35070981 |
39 | BTK | 1.30434591 |
40 | PRKD2 | 1.29829895 |
41 | MAP3K1 | 1.29501073 |
42 | TNK2 | 1.27243082 |
43 | PIM2 | 1.23786895 |
44 | ICK | 1.20969664 |
45 | RIPK1 | 1.20552501 |
46 | BUB1 | 1.17413576 |
47 | PIM1 | 1.16167403 |
48 | TAOK1 | 1.15459436 |
49 | IKBKE | 1.09642192 |
50 | MAP3K8 | 1.09616731 |
51 | CDK4 | 1.06387493 |
52 | MAP3K3 | 1.04730370 |
53 | EPHA2 | 1.04579055 |
54 | RPS6KB2 | 1.04007062 |
55 | KIT | 1.01538539 |
56 | CHUK | 0.94072914 |
57 | LMTK2 | 0.93734490 |
58 | IKBKB | 0.93730918 |
59 | MAPK12 | 0.93058146 |
60 | SCYL2 | 0.89797462 |
61 | SIK3 | 0.87804448 |
62 | JAK1 | 0.87661359 |
63 | CSF1R | 0.87346711 |
64 | CSK | 0.83651105 |
65 | LIMK1 | 0.83564256 |
66 | WEE1 | 0.82612242 |
67 | BMX | 0.82436120 |
68 | MARK2 | 0.81550312 |
69 | ABL2 | 0.81059801 |
70 | PDPK1 | 0.77762110 |
71 | TAOK2 | 0.77610043 |
72 | IRAK3 | 0.77160622 |
73 | JAK2 | 0.77077035 |
74 | MAP2K2 | 0.76933399 |
75 | HIPK2 | 0.76635835 |
76 | MOS | 0.76106107 |
77 | MTOR | 0.76035243 |
78 | MAPK11 | 0.75170098 |
79 | NEK1 | 0.74050564 |
80 | CDC42BPA | 0.72845928 |
81 | CDK7 | 0.70919718 |
82 | ITK | 0.69168724 |
83 | CDK6 | 0.67975638 |
84 | MARK3 | 0.66364734 |
85 | MAPK7 | 0.65823970 |
86 | HCK | 0.65221677 |
87 | RPS6KL1 | 0.64670500 |
88 | RPS6KC1 | 0.64670500 |
89 | STK4 | 0.64089934 |
90 | SIK2 | 0.63194757 |
91 | LYN | 0.63087164 |
92 | RPS6KA2 | 0.62680282 |
93 | TGFBR1 | 0.61788931 |
94 | ALK | 0.60268518 |
95 | DYRK1B | 0.59915061 |
96 | KSR2 | 0.59635807 |
97 | DYRK3 | 0.58831290 |
98 | FGR | 0.57618566 |
99 | PDK1 | 0.57010327 |
100 | GRK7 | 0.56536992 |
101 | TESK1 | 0.55960699 |
102 | LCK | 0.55312669 |
103 | MAP3K7 | 0.55031932 |
104 | SYK | 0.53856093 |
105 | MAP2K6 | 0.53418259 |
106 | MATK | 0.51453904 |
107 | IRAK2 | 0.49454964 |
108 | TXK | 0.48917604 |
109 | PTK2B | 0.48634079 |
110 | MAP3K14 | 0.48502661 |
111 | BRAF | 0.48145233 |
112 | FGFR3 | 0.48007590 |
113 | TAOK3 | 0.47338698 |
114 | MAPKAPK2 | 0.46265901 |
115 | DAPK3 | 0.45636107 |
116 | EPHA3 | 0.45399227 |
117 | CAMK1D | 0.45106843 |
118 | MAPK4 | 0.44415550 |
119 | PRKD1 | 0.43304252 |
120 | PRKG2 | 0.42132611 |
121 | PIK3CG | 0.41478644 |
122 | MYLK | 0.41459372 |
123 | TEC | 0.41409214 |
124 | PTK2 | 0.40697639 |
125 | MAP3K6 | 0.40675616 |
126 | RPS6KA1 | 0.39860512 |
127 | PAK1 | 0.38512047 |
128 | TTK | 0.37356424 |
129 | NLK | 0.36709771 |
130 | ACVR1B | 0.35479807 |
131 | TIE1 | 0.35416104 |
132 | TSSK6 | 0.35388625 |
133 | PDGFRA | 0.35216597 |
134 | EIF2AK1 | 0.35043659 |
135 | IRAK4 | 0.34588814 |
136 | ILK | 0.34272427 |
137 | PAK2 | 0.34224916 |
138 | MST4 | 0.33627029 |
139 | RPS6KA6 | 0.33509115 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 2.10412907 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04706981 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00056189 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88998349 |
5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86340725 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84648153 |
7 | Malaria_Homo sapiens_hsa05144 | 1.83567152 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83354519 |
9 | DNA replication_Homo sapiens_hsa03030 | 1.74950533 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67346171 |
11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60899554 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60299215 |
13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59763593 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50682366 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45662328 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45189315 |
17 | Base excision repair_Homo sapiens_hsa03410 | 1.41740030 |
18 | Asthma_Homo sapiens_hsa05310 | 1.41635799 |
19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39904187 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36657275 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31272674 |
22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30019383 |
23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29423531 |
24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29303306 |
25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28533631 |
26 | Measles_Homo sapiens_hsa05162 | 1.25777699 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.24958508 |
28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23274410 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21080658 |
30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20267522 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19366315 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17896512 |
33 | Phagosome_Homo sapiens_hsa04145 | 1.17557099 |
34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17372393 |
35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16401275 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.13737551 |
37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13550625 |
38 | Hepatitis C_Homo sapiens_hsa05160 | 1.13477402 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13223641 |
40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12047151 |
41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09771908 |
42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09438346 |
43 | Salmonella infection_Homo sapiens_hsa05132 | 1.07359982 |
44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06949675 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06635154 |
46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06419526 |
47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03629012 |
48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02585771 |
49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00784840 |
50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00163394 |
51 | Influenza A_Homo sapiens_hsa05164 | 1.00151826 |
52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99536224 |
53 | Shigellosis_Homo sapiens_hsa05131 | 0.99193185 |
54 | Ribosome_Homo sapiens_hsa03010 | 0.98015221 |
55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97889573 |
56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97317917 |
57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96881490 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96218980 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96098826 |
60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95694204 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94306391 |
62 | Lysosome_Homo sapiens_hsa04142 | 0.93965726 |
63 | Endocytosis_Homo sapiens_hsa04144 | 0.93288185 |
64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93238270 |
65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92809101 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 0.91990124 |
67 | Platelet activation_Homo sapiens_hsa04611 | 0.91833540 |
68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90963626 |
69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90939192 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90517076 |
71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90334022 |
72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90227599 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89912381 |
74 | Mismatch repair_Homo sapiens_hsa03430 | 0.89422723 |
75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88437627 |
76 | Spliceosome_Homo sapiens_hsa03040 | 0.88273950 |
77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87182113 |
78 | RNA transport_Homo sapiens_hsa03013 | 0.87109483 |
79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86133684 |
80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85156199 |
81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85046609 |
82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83924421 |
83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83843587 |
84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83817543 |
85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82919436 |
86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82378245 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.81958009 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80358311 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.79099265 |
90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78766227 |
91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78357152 |
92 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76358669 |
93 | Bladder cancer_Homo sapiens_hsa05219 | 0.74938673 |
94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74543154 |
95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74238456 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73790945 |
97 | Hepatitis B_Homo sapiens_hsa05161 | 0.73343814 |
98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72263883 |
99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71746449 |
100 | Pertussis_Homo sapiens_hsa05133 | 0.71462309 |
101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71138555 |
102 | * Insulin resistance_Homo sapiens_hsa04931 | 0.69750007 |
103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67185124 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66860334 |
105 | Cell cycle_Homo sapiens_hsa04110 | 0.66561094 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66324377 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66014954 |
108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65391926 |
109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64451011 |
110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64007479 |
111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63134756 |
112 | Tuberculosis_Homo sapiens_hsa05152 | 0.63058637 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61642343 |
114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60410358 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59744175 |
116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59085672 |
117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58999461 |
118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58168882 |
119 | ABC transporters_Homo sapiens_hsa02010 | 0.57994152 |
120 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57261958 |
121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56267721 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55995495 |
123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55682802 |
124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55369758 |
125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55057424 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54981975 |
127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54040471 |
128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53719503 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53623235 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50946677 |
131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50190383 |
132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48546939 |
133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48282596 |
134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47267979 |
135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42815209 |
136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41511324 |
137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40298639 |
138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40270175 |
139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39979763 |
140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33586234 |